Vitality Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VBIO and buy or sell other stocks, ETFs, and their options commission-free!

About VBIO

Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. 

CEO
Michael Cavanaugh, MBA
CEOMichael Cavanaugh, MBA
Employees
15
Employees15
Headquarters
Cleveland, Ohio
HeadquartersCleveland, Ohio
Founded
2007
Founded2007
Employees
15
Employees15

VBIO Key Statistics

Market cap
43.79M
Market cap43.79M
Price-Earnings ratio
12.38
Price-Earnings ratio12.38
Dividend yield
Dividend yield
Average volume
11.27K
Average volume11.27K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.249
52 Week high$0.249
52 Week low
$0.09
52 Week low$0.09

Stock Snapshot

With a market cap of 43.79M, Vitality Biopharma(VBIO) trades at $0.39. The stock has a price-to-earnings ratio of 12.38.

Vitality Biopharma(VBIO) stock opened on 2026-03-03 at —. The price climbed to — and dipped to —.

Vitality Biopharma(VBIO) shares are trading with a volume of 0, against a daily average of 11.27K.

In the last year, Vitality Biopharma(VBIO) shares hit a 52-week high of $0.25 and a 52-week low of $0.09.

In the last year, Vitality Biopharma(VBIO) shares hit a 52-week high of $0.25 and a 52-week low of $0.09.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.